Healthcare & Medical Devices Global On demand · 24-48h

Global Extracorporeal Shock Wave Lithotripsy Machine Market Strategic Research Report

Global Extracorporeal Shock Wave Lithotripsy Machine Market …
$3,500 USD
Market Research Reports
Strategic Research Report
Global Extracorporeal Shock Wave Lithotripsy Machine Market
$4112025
5.3%CAGR
2032Forecast
Market Research Reports · Global
Market Research Reports Intelligence Series

By Type: Fluoroscopy-Guided Localization, Ultrasound-Guided Localization, X-Ray + Ultrasound

By Application: Kidney Stones, Biliary Calculi, Salivary Stones, Pancreatic Stones, Others

Regional Forecast: Asia Pacific, Latin America, MEA, Europe, North America

Key Players: WIKKON (AMTH), HYDE, Sody, Haibin, Comermy, New Element Medical, Dornier, Richard-Wolf, MTS, Initia (DirexGroup), Siemens, Focal One (EDAP TMS), Storz, Medispec, ELMED, Inceler Medikal, US, Allengers

Region: Global
Formats: PDF, Excel, Word & PowerPoint
Base year: 2025 · forecast to 2032
Length: 142 pages
Market size 2025
$411
Million USD
Forecast CAGR
5.3%
2025-2032
Forecast 2032
$590
Projected
Regions
5
Asia Pacific · Latin America · MEA · Europe · North America

نظرة عامة

Scope of the Report

The global Extracorporeal Shock Wave Lithotripsy Machine market size is predicted to grow from US$ 411 million in 2025 to US$ 586 million in 2032; it is expected to grow at a CAGR of 5.3% from 2026 to 2032.

Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive treatment of kidney stones and gallbladder stones. Major principle behind the treatment is breaking of the kidney stones by passing shock waves from outside the body targeted at kidney stones. Stones that are between 4 mm (0.16 in.) and 2 cm (0.8 in.) in diameter are most likely to be treated with ESWL used at rate of 60-90 shocks/minute to achieve optimal stone fragmentation. ESWL is usually not used if you: Are pregnant. The sound waves and X-rays may be harmful to the fetus./Have a bleeding disorder./Have a kidney infection, urinary tract infection, or kidney cancer./Have kidneys with abnormal structure or function. Extracorporeal shock wave lithotripsy (ESWL) is a core device for non-invasive stone treatment. Its classification is mainly based on energy source and positioning method, and its application is concentrated in urology. The product has an average price of approximately $90,000 and global sales of approximately 4,669 units.

The upstream of the extracorporeal shock wave lithotripsy (ESWL) industry chain mainly includes high-energy shock wave generators (electrohydraulic, electromagnetic, piezoelectric), image positioning systems (X-ray/ultrasound), and medical-grade materials and components, such as high-voltage power supplies, focusing lenses, and ultrasound probes. These determine the accuracy and reliability of the equipment. Downstream applications include general hospitals, urology hospitals, outpatient lithotripsy centers, and some extended applications in bile duct stones and rehabilitation medicine (musculoskeletal shock wave therapy). Future development trends focus on dual-mode positioning (X-ray + ultrasound), low-energy multiple shocks to reduce tissue damage, and intelligent lithotripsy monitoring systems. Simultaneously, with the rising incidence of stones, an aging population, and increased demand for non-invasive treatments, the market will maintain stable growth. The construction of commercial aerospace medical and regional lithotripsy centers will also drive the miniaturization and mobility of equipment, making it more suitable for primary healthcare institutions.

Key Questions Addressed in this Report

What is the 10-year outlook for the global Extracorporeal Shock Wave Lithotripsy Machine market?

What factors are driving Extracorporeal Shock Wave Lithotripsy Machine market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Extracorporeal Shock Wave Lithotripsy Machine market opportunities vary by end market size?

How does Extracorporeal Shock Wave Lithotripsy Machine break out by Type, by Application?

This report presents a comprehensive overview of the global Extracorporeal Shock Wave Lithotripsy Machine market, covering market size and forecast, segmentation by product type and application, competitive landscape, leading players and regional and country-level outlook.

Segment by Type

  • Fluoroscopy-Guided Localization
  • Ultrasound-Guided Localization
  • X-Ray + Ultrasound

Segment by Energy Source

  • Electrohydraulic
  • Piezoelectric
  • Electromagnetic

Segment by Equipment Type

  • Fixed
  • Mobile

Segment by Application

  • Kidney Stones
  • Biliary Calculi
  • Salivary Stones
  • Pancreatic Stones
  • Others

Who Can Use This Report?

This report is written for decision-makers who need a clear, data-backed view of the global Extracorporeal Shock Wave Lithotripsy Machine market:

  • Manufacturers, suppliers and solution providers benchmarking their position and planning product, capacity and go-to-market strategy
  • Distributors, channel partners and end users in Kidney Stones, Biliary Calculi, Salivary Stones evaluating demand and sourcing options
  • Investors, financial analysts and consultants assessing growth opportunities, competitive dynamics and M&A potential
  • Government agencies, industry associations and research institutions tracking industry developments and policy impact

Market snapshot

Global Extracorporeal Shock Wave Lithotripsy Machine Market Strategic Research Report snapshot, 2025–2032

Source: Market Research Reports
Market size CAGR 5.3%
Regional growth momentum
Market share by segment
Key metrics
Base value
$411
2025
Forecast
$590
2032
CAGR
5.3%
2025–2032
Regions
5
global
Key companies
WIKKON (AMTH)HYDESodyHaibinComermyNew Element MedicalDornierRichard-Wolf
© MarketResearchReports.comDisclaimer: The actual data may vary in the final report which undergoes verification check post order confirmation.

Segments covered in this report

By Type
Fluoroscopy-Guided LocalizationUltrasound-Guided LocalizationX-Ray + Ultrasound
By Application
Kidney StonesBiliary CalculiSalivary StonesPancreatic StonesOthers

Table of contents

Click a chapter to expand
01Executive Summary
02Industry Overview & Forecast
  • 2.1.1 Market Definition and Scope
  • 2.1.2 Market Size and Growth Forecast
  • 2.1.3 Volume Analysis
  • 2.1.4 Segment Outlook by Type
  • 2.1.5 Segment Outlook by Application
  • 2.1.6 Regional Outlook
  • 2.1.7 Structural Developments Shaping the Forecast
  • 2.1.8 Forecast Risks and Sensitivities
03Market Segmentation by Type
  • 3.1 Market Segmentation by Type
  • 3.1.1 Market by Type Overview
  • 3.1.2 Fluoroscopy-Guided Localization
  • 3.1.3 Ultrasound-Guided Localization
  • 3.1.4 X-Ray + Ultrasound
  • 3.1.5 Volume Analysis
04Market Segmentation by Application
  • 4.1 Market Segmentation by Application
  • 4.1.1 Market by Application Overview
  • 4.1.2 Kidney Stones
  • 4.1.3 Biliary Calculi
  • 4.1.4 Salivary Stones
  • 4.1.5 Pancreatic Stones
  • 4.1.6 Others
  • 4.1.7 Volume Analysis
05Regional Market Forecast
  • Asia Pacific
  • North America
  • Europe
  • Middle East & Africa
  • Latin America
06Country-Level Market Forecast
  • 6.1 Asia Pacific
  • 6.1.1 China
  • 6.1.2 Japan
  • 6.1.3 Korea
  • 6.1.4 Southeast Asia
  • 6.1.5 India
  • 6.1.6 Australia
  • 6.1.7 Rest of Asia Pacific
  • 6.2 North America
  • 6.2.1 United States
  • 6.2.2 Canada
  • 6.2.3 Mexico
  • 6.2.4 Rest of North America
  • 6.3 Europe
  • 6.3.1 Germany
  • 6.3.2 France
  • 6.3.3 UK
  • 6.3.4 Italy
  • 6.3.5 Russia
  • 6.3.6 Rest of Europe
  • 6.4 Middle East & Africa
  • 6.4.1 Egypt
  • 6.4.2 South Africa
  • 6.4.3 Israel
  • 6.4.4 Turkey
  • 6.4.5 GCC Countries
  • 6.4.6 Rest of Middle East & Africa
  • 6.5 Latin America
  • 6.5.1 Brazil
  • 6.5.2 Rest of Latin America
07Growth Drivers & Inhibitors
  • 7.1 Growth Drivers & Inhibitors
  • 7.1.1 Section Overview
  • 7.1.2 Growth Drivers
  • 7.1.3 Growth Inhibitors
  • 7.1.4 Driver and Inhibitor Impact Assessment
  • 7.1.5 Analyst Perspective
08Key Company Profiles
  • 8.1 WIKKON (AMTH)
  • 8.1.1 Company Overview
  • 8.1.2 Key Products & Segments
  • 8.1.3 Financial Performance (2023–2025)
  • 8.1.4 Business Strategy
  • 8.1.5 SWOT Analysis
  • 8.1.6 Strategic Implications (2026–2032)
  • 8.2 HYDE
  • 8.2.1 Company Overview
  • 8.2.2 Key Products & Segments
  • 8.2.3 Financial Performance (2023–2025)
  • 8.2.4 Business Strategy
  • 8.2.5 SWOT Analysis
  • 8.2.6 Strategic Implications (2026–2032)
  • 8.3 Sody
  • 8.3.1 Company Overview
  • 8.3.2 Key Products & Segments
  • 8.3.3 Financial Performance (2023–2025)
  • 8.3.4 Business Strategy
  • 8.3.5 SWOT Analysis
  • 8.3.6 Strategic Implications (2026–2032)
  • 8.4 Haibin
  • 8.4.1 Company Overview
  • 8.4.2 Key Products & Segments
  • 8.4.3 Financial Performance (2023–2025)
  • 8.4.4 Business Strategy
  • 8.4.5 SWOT Analysis
  • 8.4.6 Strategic Implications (2026–2032)
  • 8.5 Comermy
  • 8.5.1 Company Overview
  • 8.5.2 Key Products & Segments
  • 8.5.3 Financial Performance (2023–2025)
  • 8.5.4 Business Strategy
  • 8.5.5 SWOT Analysis
  • 8.5.6 Strategic Implications (2026–2032)
  • 8.6 New Element Medical
  • 8.6.1 Company Overview
  • 8.6.2 Key Products & Segments
  • 8.6.3 Financial Performance (2023–2025)
  • 8.6.4 Business Strategy
  • 8.6.5 SWOT Analysis
  • 8.6.6 Strategic Implications (2026–2032)
  • 8.7 Dornier
  • 8.7.1 Company Overview
  • 8.7.2 Key Products & Segments
  • 8.7.3 Financial Performance (2023–2025)
  • 8.7.4 Business Strategy
  • 8.7.5 SWOT Analysis
  • 8.7.6 Strategic Implications (2026–2032)
  • 8.8 Richard-Wolf
  • 8.8.1 Company Overview
  • 8.8.2 Key Products & Segments
  • 8.8.3 Financial Performance (2023–2025)
  • 8.8.4 Business Strategy
  • 8.8.5 SWOT Analysis
  • 8.8.6 Strategic Implications (2026–2032)
  • 8.9 MTS
  • 8.9.1 Company Overview
  • 8.9.2 Key Products & Segments
  • 8.9.3 Financial Performance (2023–2025)
  • 8.9.4 Business Strategy
  • 8.9.5 SWOT Analysis
  • 8.9.6 Strategic Implications (2026–2032)
  • 8.10 Initia (DirexGroup)
  • 8.10.1 Company Overview
  • 8.10.2 Key Products & Segments
  • 8.10.3 Financial Performance (2023–2025)
  • 8.10.4 Business Strategy
  • 8.10.5 SWOT Analysis
  • 8.10.6 Strategic Implications (2026–2032)
  • 8.11 Siemens
  • 8.11.1 Company Overview
  • 8.11.2 Key Products & Segments
  • 8.11.3 Financial Performance (2023–2025)
  • 8.11.4 Business Strategy
  • 8.11.5 SWOT Analysis
  • 8.11.6 Strategic Implications (2026–2032)
  • 8.12 Focal One (EDAP TMS)
  • 8.12.1 Company Overview
  • 8.12.2 Key Products & Segments
  • 8.12.3 Financial Performance (2023–2025)
  • 8.12.4 Business Strategy
  • 8.12.5 SWOT Analysis
  • 8.12.6 Strategic Implications (2026–2032)
  • 8.13 Storz
  • 8.13.1 Company Overview
  • 8.13.2 Key Products & Segments
  • 8.13.3 Financial Performance (2023–2025)
  • 8.13.4 Business Strategy
  • 8.13.5 SWOT Analysis
  • 8.13.6 Strategic Implications (2026–2032)
  • 8.14 Medispec
  • 8.14.1 Company Overview
  • 8.14.2 Key Products & Segments
  • 8.14.3 Financial Performance (2023–2025)
  • 8.14.4 Business Strategy
  • 8.14.5 SWOT Analysis
  • 8.14.6 Strategic Implications (2026–2032)
  • 8.15 ELMED
  • 8.15.1 Company Overview
  • 8.15.2 Key Products & Segments
  • 8.15.3 Financial Performance (2023–2025)
  • 8.15.4 Business Strategy
  • 8.15.5 SWOT Analysis
  • 8.15.6 Strategic Implications (2026–2032)
  • 8.16 Inceler Medikal
  • 8.16.1 Company Overview
  • 8.16.2 Key Products & Segments
  • 8.16.3 Financial Performance (2023–2025)
  • 8.16.4 Business Strategy
  • 8.16.5 SWOT Analysis
  • 8.16.6 Strategic Implications (2026–2032)
  • 8.17 US
  • 8.17.1 Company Overview
  • 8.17.2 Key Products & Segments
  • 8.17.3 Financial Performance (2023–2025)
  • 8.17.4 Business Strategy
  • 8.17.5 SWOT Analysis
  • 8.17.6 Strategic Implications (2026–2032)
  • 8.18 Allengers
  • 8.18.1 Company Overview
  • 8.18.2 Key Products & Segments
  • 8.18.3 Financial Performance (2023–2025)
  • 8.18.4 Business Strategy
  • 8.18.5 SWOT Analysis
  • 8.18.6 Strategic Implications (2026–2032)
09Competitive Landscape
  • 9.1 Competitive Landscape Overview
  • 9.2 Competitive Intensity Assessment
  • 9.3 Key Player Strategies & Positioning
  • 9.4 Competitive Dynamics & Strategic Outlook
  • 9.4.1 Emerging Competitive Threats
  • 9.4.2 Consolidation vs. Fragmentation Outlook
  • 9.4.3 Competitive Response Matrix
  • 9.4.4 Strategic Recommendations, 2026–2032
10Porter's Five Forces Analysis
  • 10.1 Threat of New Entrants
  • 10.2 Bargaining Power of Buyers
  • 10.3 Bargaining Power of Suppliers
  • 10.4 Threat of Substitutes
  • 10.5 Competitive Rivalry
11PESTLE Analysis
  • 11.1 Political
  • 11.2 Economic
  • 11.3 Social and Demographic
  • 11.4 Technological
  • 11.5 Legal and Regulatory
  • 11.6 Environmental
  • 11.7 Strategic Implications of the PESTLE Assessment
12SWOT Analysis
13Future Trends & Outlook
  • 13.1 Future Trends & Outlook
  • 13.1.1 Trend Summary and Commercial Maturity Assessment
  • 13.1.2 Technology and Innovation Trends
  • 13.1.3 Long-Term Market Outlook
  • 13.1.4 Investment & M&A Activity Outlook
  • 13.1.5 Overall Outlook Assessment

Frequently asked questions

What is the size of the global Extracorporeal Shock Wave Lithotripsy Machine market?
The global Extracorporeal Shock Wave Lithotripsy Machine market is estimated at US$ 411 million in 2025 (base year) and is projected to reach US$ 586 million by 2032.
What is the forecast CAGR for the Extracorporeal Shock Wave Lithotripsy Machine market?
The market is expected to grow at a CAGR of 5.3% from 2026 to 2032, expanding from US$ 411 million in 2025 to US$ 586 million in 2032, roughly 1.4 times its base-year value.
What is Extracorporeal Shock Wave Lithotripsy Machine?
Extracorporeal shock wave lithotripsy (ESWL) is a non-invasive treatment of kidney stones and gallbladder stones. Major principle behind the treatment is breaking of the kidney stones by passing shock waves from outside the body targeted at kidney stones. Stones that are between 4 mm (0.16 in.) and 2 cm (0.8 in.) in diameter are most likely to be treated with ESWL used at rate of 60-90 shocks/minute to achieve optimal stone fragmentation.
How is the Extracorporeal Shock Wave Lithotripsy Machine market segmented by type?
By type, the market is segmented into Fluoroscopy-Guided Localization, Ultrasound-Guided Localization and X-Ray + Ultrasound.
What are the key applications of Extracorporeal Shock Wave Lithotripsy Machine?
Key applications covered include Kidney Stones, Biliary Calculi, Salivary Stones, Pancreatic Stones and Others.
Which companies are profiled in the Extracorporeal Shock Wave Lithotripsy Machine market report?
Key players profiled include WIKKON (AMTH), HYDE, Sody, Haibin, Comermy, New Element Medical, Dornier and Richard-Wolf, among 18 companies covered in total.
What geographies does the Extracorporeal Shock Wave Lithotripsy Machine market analysis include?
The market is analysed across Asia Pacific, North America, Europe, Middle East & Africa and Latin America, with 20 country-level markets including China, Japan, United States, Canada, Germany, France, Egypt and South Africa.
What are the key demand drivers for Extracorporeal Shock Wave Lithotripsy Machine?
What factors are driving Extracorporeal Shock Wave Lithotripsy Machine market growth, globally and by region?
Who should buy the Extracorporeal Shock Wave Lithotripsy Machine market report?
The report is intended for manufacturers and solution providers, distributors and end users in Kidney Stones, Biliary Calculi and Salivary Stones, investors and consultants, and government or industry bodies who need market size, segmentation, competitive and regional data for the Extracorporeal Shock Wave Lithotripsy Machine market.
What license options are available for this report?
The report is available as a Single User License (US$ 3,500, one named user), a Site License (US$ 5,250, up to 10 users) and a Global / Corporate License (US$ 7,000, unlimited users), all delivered in PDF format.

Research Methodology

All MarketResearchReports.com strategic research reports follow a rigorous, multi-stage methodology combining AI-assisted data synthesis with expert analyst validation.

01
Secondary Research & Data Aggregation

Systematic collection from 500+ verified sources including SEC filings, industry databases (Bloomberg, Statista, OECD), regulatory filings, trade publications, patent databases, and company annual reports. AI-assisted extraction identifies relevant data points across 10,000+ documents per report.

02
Market Sizing — Bottom-Up & Top-Down

Dual-validation approach: bottom-up sizing aggregates segment-level production, consumption, and trade data; top-down sizing cross-validates against macroeconomic indicators and total addressable market estimates. Discrepancies >5% trigger analyst review.

03
Competitive Intelligence

Company profiles built from public financial disclosures, product launches, M&A activity, job postings (as capability proxies), and supply chain mapping. Market share estimates triangulated across revenue, capacity, and shipment data.

04
Demand Forecasting

CAGR projections use time-series regression on 5-10 years of historical data, adjusted for identified demand drivers (technology adoption curves, regulatory catalysts, demographic shifts) and demand inhibitors (cost barriers, substitution risk). Scenario modeling covers base, optimistic, and conservative cases.

05
Analyst Validation & Quality Assurance

All quantitative outputs reviewed by a domain-specialist analyst before publication. Data triangulation requires minimum 3 independent sources for every key figure. Reports undergo a structured peer review against our 47-point quality checklist covering methodology, data citations, logical consistency, and formatting standards.

06
Continuous Updates

On-demand reports are generated at time of purchase, incorporating the most recent available data. Static reports are republished when underlying market conditions shift by >10% from baseline assumptions. Purchasers receive update notifications for 12 months.

Select a license
from ‏3,500.00 US$
Report License Type
Optional add-ons
On demand · delivered within 24-48 hours
Secure checkout · SSL encrypted
License terms included
Post-purchase analyst support
Custom research

Need a customized version?

Get country-, segment- or company-specific intelligence tailored to your exact requirements.

Request custom research →
Talk to a research advisor USA: +1-302-703-9904 India: +91-8762746600
Trusted by

Leading Brands in This Industry

Logos are trademarks of their respective owners and indicate a verified past business relationship, not a current partnership or endorsement.